Tanaka Issei, Sato Yutaka, Sano Chiaki, Ohta Ryuichi
Family Medicine, International University of Health and Welfare Graduate School of Health Sciences, Tokyo, JPN.
Community Care, Unnan City Hospital, Unnan, JPN.
Cureus. 2024 Oct 30;16(10):e72681. doi: 10.7759/cureus.72681. eCollection 2024 Oct.
An 89-year-old woman, living independently, presented to a community hospital with complaints of back pain and anterior chest pain after a fall at home. During her hospitalization, she was infected with COVID-19, and although her fever temporarily resolved with symptomatic treatment, she developed pancytopenia and liver dysfunction along with fever again. Blood tests and imaging studies ruled out acute cholangitis or hepatitis virus infection, and a diagnosis of myelosuppression and liver dysfunction due to multi-system inflammatory syndrome (MIS) was made. Treatment with prednisolone was initiated, and improvement in liver enzyme levels and pancytopenia was observed, indicating that steroid therapy was effective. Still, after steroid discontinuation, the patient again presented with pancytopenia. This case demonstrates the potential of multiorgan damage that can occur after a COVID-19 infection and emphasizes the importance of tapering and monitoring steroid therapy, especially in the management of myelosuppression and liver dysfunction due to MIS, during a COVID-19 infection. This may contribute to improved patient prognosis.
一名89岁独居女性在家中跌倒后因背痛和前胸疼痛前往一家社区医院就诊。住院期间,她感染了新冠病毒,尽管经对症治疗后发热暂时消退,但她再次出现发热,并伴有全血细胞减少和肝功能障碍。血液检查和影像学检查排除了急性胆管炎或肝炎病毒感染,诊断为多系统炎症综合征(MIS)所致的骨髓抑制和肝功能障碍。开始使用泼尼松龙治疗,观察到肝酶水平和全血细胞减少有所改善,表明类固醇治疗有效。然而,停用类固醇后,患者再次出现全血细胞减少。该病例表明新冠病毒感染后可能发生多器官损伤,并强调了逐渐减少类固醇剂量并进行监测的重要性,尤其是在新冠病毒感染期间MIS所致骨髓抑制和肝功能障碍的管理中。这可能有助于改善患者预后。